Organon Shareholders Overwhelmingly Approve $14/Share Sale to Sun Pharma
OGN has more than doubled off its 52-week low of $5.69.
Summary
Organon shareholders approved the $14.00 per share acquisition by Sun Pharmaceutical with 98.7% of votes in favor, clearing the path for the merger to close.
Key Events · M&A and Partnerships · OGN
-
Merger Agreement Approved
Shareholders voted 192.8 million shares for, 2.6 million against, and 326,189 abstaining to adopt the merger agreement with Sun Pharmaceutical.
-
Advisory Compensation Vote Passes
The non-binding proposal on merger-related executive compensation was approved with 185.1 million votes for, 9.6 million against, and 980,043 abstaining.
-
Strong Quorum and Overwhelming Support
74.51% of outstanding shares were represented at the special meeting, with 98.7% of votes cast in favor of the merger.
-
Deal Closing Next Step
With shareholder approval secured, the merger is expected to close subject to remaining customary conditions; the $14.00 per share cash deal represents a 3.2% premium to today's price.
Analysis · OGN · Life Sciences
Organon shareholders voted decisively to approve the merger with Sun Pharmaceutical, with 98.7% of votes cast in favor. The vote clears the last major hurdle before closing, despite a last-minute lawsuit attempting to block the meeting. With the stock trading at $13.56, just below the $14.00 deal price, the approval removes uncertainty and signals the deal is on track to close.
How filings like this one have moved
In the 30 days to Oct 4, 2026, 36.6% of the 1018 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, OGN was trading at $13.56 on NYSE in the Life Sciences sector, with a market capitalization of approximately $3.6B. The 52-week trading range was $5.69 to $13.60. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.